Neurotronic Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
Clinical trial NCT04232774 · COMPLETED
Trial details
- NCT number
- NCT04232774
- Sponsor
- Neurotronic, Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-04
- Primary completion
- 2023-01-17
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.